Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a total operating revenue of 354 million yuan for the first three quarters of 2024, representing a year-on-year increase of 15.88%. The total profit reached 106 million yuan, up 20.35% year-on-year, with a net profit attributable to the parent company of 99 million yuan, also up 20.3% year-on-year. However, in Q3 2024, the company achieved revenue of 78 million yuan, a decrease of 25.67%, and a net profit of 25 million yuan, down 33.72% [2] - Profitability improved sequentially, with a significant increase in contract liabilities. The gross margin and net margin for Q3 2024 were 68.47% and 31.22%, respectively, up 3.24 percentage points and 3.97 percentage points from Q2. Compared to Q3 2023, the gross margin increased by 1.47 percentage points, while the net margin decreased by 4.21 percentage points due to increased expenses, with sales expenses rising by 26.73% and R&D expenses by 46.99%. The total contract liabilities for Q1-Q3 2024 amounted to 31 million yuan, a substantial increase of 74% from the end of 2023, mainly due to an increase in customer prepayments [2] - The company's core products have high reliability and are continuously expanding into new application scenarios. The company has focused on the measurement and control industry for many years, with its core sensor products being highly reliable and stable, suitable for various harsh environments. Recent product launches include the DH7955 rugged high-performance motion controller designed for vehicle, aircraft, and shipborne applications. Additionally, the DH59 series data acquisition and analysis system provided strong technical support for the recent satellite launch mission [2] - The long-term development of the company is viewed positively, but the earnings forecast has been adjusted due to macroeconomic impacts. The projected revenues for 2024-2026 are 530 million, 700 million, and 910 million yuan, respectively, with year-on-year growth rates of 40%, 32%, and 30%. The net profit attributable to the parent company is expected to be 150 million, 210 million, and 280 million yuan, with corresponding year-on-year growth rates of 68%, 40%, and 35%. The earnings per share (EPS) for the total share capital is projected to be 1.07, 1.50, and 2.02 yuan, with price-to-earnings (P/E) ratios of 29, 21, and 15 times at the current stock price [2][3][4] Financial Summary - For 2023, the company reported an operating income of 378 million yuan, with a year-on-year growth of 3.0%. The net profit attributable to the parent company was 88 million yuan, down 27.9% year-on-year. The gross margin was 65.5%, and the return on equity (ROE) was 13.9% [3] - The financial projections for 2024 estimate operating income of 529 million yuan, a year-on-year increase of 39.8%, and a net profit of 148 million yuan, with a significant year-on-year growth of 68.4%. The gross margin is expected to be 65.2%, and the ROE is projected to rise to 20.3% [3][4] - By 2026, the company anticipates an operating income of 911 million yuan, with a year-on-year growth of 30.2%, and a net profit of 280 million yuan, reflecting a year-on-year growth of 35.1%. The gross margin is expected to slightly improve to 65.4%, and the ROE is projected to reach 25.6% [3][4]

Investment Rating - The report maintains a "Strong Buy" rating for the company with a target price of 45.1 RMB, compared to the current price of 34.71 RMB [1] Core Views - The company's Q3 performance was under pressure, with revenue of 0.78 billion RMB, up 25.67% YoY, and net profit of 0.25 billion RMB, down 33.72% YoY, likely due to long order confirmation cycles [1] - The company's order growth is strong, with inventory and contract liabilities increasing by 19.1% and 28.11% YoY respectively by the end of Q3 2024 [1] - High profitability continues, with gross and net profit margins of 66.55% and 27.82% respectively for Q1-Q3 2024, up 0.18pct and 0.88pct YoY [1] - The company is well-positioned to benefit from domestic substitution and increasing penetration of PHM (Prognostics and Health Management) in the defense and industrial sectors [1] Financial Performance - For Q1-Q3 2024, the company achieved revenue of 3.54 billion RMB, up 15.88% YoY, and net profit of 0.99 billion RMB, up 20.3% YoY [1] - The company's revenue is expected to grow to 6.03 billion RMB in 2024, 7.96 billion RMB in 2025, and 10.17 billion RMB in 2026, with YoY growth rates of 59.3%, 32.1%, and 27.8% respectively [1] - Net profit is forecasted to reach 1.88 billion RMB in 2024, 2.49 billion RMB in 2025, and 3.26 billion RMB in 2026, with YoY growth rates of 114.5%, 32.4%, and 30.7% respectively [1] Industry Outlook - The domestic substitution trend and increasing PHM penetration in the defense and industrial sectors are expected to drive the company's growth [1] - The company's structural mechanics performance testing systems are well-positioned to benefit from the modernization and intelligent development of weapons and equipment [1] - The company's electrochemical workstations are expected to gain market share due to policy support and competitive advantages in pricing and after-sales service [1] Valuation - The company is valued at 25X PE for 2025, with a target price of 45.1 RMB [1] - The company's P/E ratio is expected to decrease from 55 in 2023 to 26 in 2024, 19 in 2025, and 15 in 2026 [2] - The company's P/B ratio is expected to decrease from 7.2 in 2023 to 5.8 in 2024, 4.6 in 2025, and 3.6 in 2026 [2]

Financial Performance - Revenue for the third quarter was RMB 78.31 million, a decrease of 25.67% year-over-year[3] - Net profit attributable to shareholders was RMB 24.74 million, down 33.72% year-over-year[3] - Operating revenue rose to 354,181,217.45 yuan from 305,634,743.52 yuan, an increase of 15.9%[15] - Net profit attributable to the parent company's owners grew to 441,609,395.55 yuan from 360,248,658.79 yuan, up by 22.6%[14] - Net profit attributable to parent company shareholders increased to RMB 99,044,982.63, up from RMB 82,331,092.00 in the previous period[16] - Basic earnings per share rose to RMB 0.7161 from RMB 0.5952[16] Assets and Liabilities - Total assets increased by 12.28% to RMB 825.53 million compared to the end of the previous year[3] - Total assets increased to 825,529,497.42 yuan from 735,266,059.22 yuan, reflecting a growth of 12.3%[14] - Total liabilities grew to 88,250,890.98 yuan from 69,073,499.04 yuan, an increase of 27.8%[14] - Fixed assets increased to 124,070,584.99 yuan from 117,807,899.38 yuan, up by 5.3%[13] - Inventory rose to 175,486,868.89 yuan from 169,659,191.35 yuan, a 3.4% increase[12] Cash Flow - Cash flow from operating activities improved by 62.21% to a net outflow of RMB 18.39 million[3] - Cash flow from operating activities improved to a net outflow of RMB -18,390,066.92, compared to RMB -48,658,883.64 in the prior period[18] - Cash received from sales of goods and services increased to RMB 267,603,509.85 from RMB 235,746,612.79[17] - Cash paid to employees and for employee benefits rose to RMB 111,344,015.19 from RMB 89,579,953.44[18] - Cash flow from investing activities showed a net outflow of RMB -16,666,409.14, an improvement from RMB -27,833,881.03[18] - Cash flow from financing activities resulted in a net outflow of RMB -9,713,936.02, compared to RMB -24,452,744.39 in the previous period[18] - Total cash and cash equivalents at the end of the period stood at RMB 29,621,324.09, up from RMB 18,192,012.98[18] - Cash and cash equivalents decreased to 30,557,296.09 yuan from 75,408,516.17 yuan, a 59.5% drop[12] Research and Development - R&D expenses increased by 46.99% to RMB 43.63 million, reflecting higher investment in research and development[7] - R&D expenses climbed to 43,629,220.65 yuan from 29,680,967.99 yuan, a 47.0% rise[15] Accounts Receivable and Contract Liabilities - Accounts receivable increased by 45.30% to RMB 368.65 million, primarily due to increased sales[6] - Accounts receivable surged to 368,653,590.39 yuan from 253,713,141.57 yuan, a 45.3% increase[12] - Contract liabilities increased by 74.00% to RMB 30.85 million, driven by higher prepayments from customers[6] - Contract liabilities increased to 30,849,777.48 yuan from 17,730,170.28 yuan, up by 74.0%[13] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 9,956[9] - Liu Shigang, the largest shareholder, holds 48.99% of the shares, totaling 67,765,930 shares[9] - Luo Mian, the second-largest shareholder, holds 5.03% of the shares, totaling 6,953,100 shares[9] - The Agricultural Bank of China - Jiao Yin Schroder Advanced Manufacturing Mixed Securities Investment Fund holds 2.67% of the shares, totaling 3,692,168 shares[9] - The China Construction Bank - Jiao Yin Schroder Qiming Mixed Securities Investment Fund holds 1.27% of the shares, totaling 1,750,916 shares[9] - Liu Shigang and Luo Mian are in a spousal relationship, indicating a potential joint action agreement[9] - Zhang Jingbing holds 1,438,000 shares, with 1,331,000 shares held through a margin trading account[9] Restricted Shares - The total number of restricted shares at the end of the period is 57,120,126, with Liu Shigang holding 50,824,447 restricted shares[10][11] - Luo Mian's restricted shares decreased by 1,200,000 during the period, leaving 5,214,825 restricted shares[10] - The total number of restricted shares decreased by 1,235,093 during the period[11] Government Subsidies and VAT Refunds - Government subsidies and VAT refunds increased by 351.57% to RMB 8.27 million[7] Credit and Asset Impairment - Credit impairment losses amounted to RMB -3,551,524.71, compared to RMB -8,970,458.46 in the prior period[16] - Asset disposal losses were RMB -3,387.84, down from RMB -121,569.73[16] Short-term Borrowing and Investment - Short-term borrowing increased by 100.00% to RMB 18.00 million, reflecting new short-term loans[6] - Investment in fixed assets decreased by 40.53% to RMB 16.68 million, reflecting reduced capital expenditure[8]

证券代码：300354 证券简称：东华测试 公告编号：2024-057 江苏东华测试技术股份有限公司 第六届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 全体董事一致认为公司《2024年第三季度报告》的编制程序、内容、格式符 合相关文件的规定；三季报编制期间，未有泄密及其他违反法律法规、《公司章 程》或损害公司利益的行为发生；公司的财务报告真实、准确、完整地反映了公 司的财务状况和经营成果，不存在任何虚假记载、误导性陈述或者重大遗漏。 审议结果：赞成7票；反对0票；弃权0票，通过。 《2024年第三季度报告》详见中国证监会创业板指定信息披露网站。 本议案已经公司董事会审计委员会审议通过 2、审议通过《关于制订<舆情管理制度>的议案》 为提高公司应对各类舆情的能力，建立快速反应和应急处置机制，及时、妥 善处理各类舆情对公司股价、公司商业信誉及正常生产经营活动造成的影响，切 实保护投资者合法权益，根据相关法律法规和规范性文件及《公司章程》的规定， 1 一、董事会会议召开情况 江苏东华测试技术股份有限公司（以下简称"公司"）于2024年1 ...

江苏东华测试技术股份有限公司 舆情管理制度 （2024 年 10 月） 第一章 总则 第一条 为提高江苏东华测试技术股份有限公司（以下简称"公司"）应对 舆情的能力，建立快速反应和应急处置机制，及时、妥善处理各类舆情对公司股 价、商业信誉及正常生产经营活动造成的影响，切实保护投资者合法权益，根据 相关法律法规和规范性文件及《公司章程》的规定，结合公司实际情况，制定本 制度。 第二条 本制度所称舆情包括： （一）报刊、电视、网络等媒体对公司进行的负面报道； （二）社会上存在的已经或将给公司造成不良影响的传言或信息； 第三条 舆情信息的分类： （一）重大舆情：指传播范围较广，严重影响公司公众形象或正常经营活动， 使公司已经或可能遭受损失，已经或可能造成公司股票及其衍生品种交易价格变 动的负面舆情； （二）一般舆情：指除重大舆情之外的其他舆情。 第二章 舆情管理的组织体系及工作职责 第四条 公司应对各类舆情（尤其是媒体质疑危机时）实行统一领导、统一 组织、快速反应、协同应对。 第五条 公司成立应对舆情处理工作领导小组（以下简称"舆情工作组"）， 由公司董事长任组长，总经理和董事会秘书担任副组长，成员由公司其他高级管 ...

二、监事会会议审议情况 证券代码：300354 证券简称：东华测试 公告编号：2024-058 江苏东华测试技术股份有限公司 第六届监事会第三次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 江苏东华测试技术股份有限公司（以下简称"公司"）于2024年10月18日在 公司会议室以现场会议的方式召开了第六届监事会第三次会议，会议通知及相关 资料于2024年10月8日通过电子邮件、直接送达方式发出。本次监事会会议应参 加表决监事5名，实际参加表决监事5名。会议由监事会主席孙丽丽主持。会议的 召集及召开程序符合《中华人民共和国公司法》及《公司章程》的规定。 监 事 会 2024 年 10 月 22 日 经与会监事认真审议与表决，形成了以下决议： 1、审议通过《关于公司2024年第三季度报告的议案》 全体监事一致认为公司《2024年第三季度报告》的编制程序、内容、格式符 合相关文件的规定；三季报编制期间，未有泄密及其他违反法律法规、《公司章 程》或损害公司利益的行为发生；公司的财务报告真实、准确、完整地反映了公 司的财务状况和经营 ...

证券代码：300354 证券简称：东华测试 公告编号：2024-054 江苏东华测试技术股份有限公司 关于控股子公司完成工商变更登记暨股权转让终止的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 江苏东华测试技术股份有限公司（以下简称"公司"）于近日收到控股子公 司上海东昊智慧氢能科技有限公司（已更名为"上海东昊数字信息技术有限公司"） 的通知，其对公司名称、经营范围等进行了变更，并已完成相关工商变更登记手 续，取得由中国（上海）自由贸易试验区临港新片区市场监督管理局换发的《营 业执照》，具体情况如下： | 变更事项 | 变更前 | 变更后 | | --- | --- | --- | | 企业名称 | 上海东昊智慧氢能科技有限公司 | 上海东昊数字信息技术有限公司 | | 经营范围 | | 一般项目：信息技术咨询服务；信息系 | | | 一般项目：技术服务、技术开发、 | 统集成服务；物联网技术研发；物联网 | | | 技术咨询、技术交流、技术转让、 | 技术服务；工业互联网数据服务；新兴 | | | 技术推广；新兴能源技术研发；在 | 能源技术研发；在 ...

Investment Rating - The investment rating for the company is "Buy" [5] Core Views - The company has shown steady revenue growth and continuous improvement in profitability, with a projected revenue of 5.4 billion, 7.1 billion, and 9.0 billion yuan for 2024-2026, and a net profit of 1.4 billion, 1.9 billion, and 2.3 billion yuan respectively, indicating a CAGR of 27.18% [2][7] - The company is a leader in structural mechanics performance testing instruments, and the development of torque sensors is expected to provide new growth opportunities [2][7] Summary by Sections Financial Performance - In H1 2024, the company achieved revenue of 276 million yuan, a year-on-year increase of 37.75%, and a net profit of 74 million yuan, up 65.11% year-on-year [7] - For Q2 2024, revenue was 172 million yuan, with a year-on-year growth of 33.60%, and net profit was 47 million yuan, increasing by 35.30% year-on-year [7] - The company's gross margin and net margin for H1 2024 were 66% and 26.85% respectively, with the net margin showing a significant increase of 4.38 percentage points year-on-year [7] Product Development - The company is actively promoting its electrochemical workstations, which have shown high growth, with revenues of 260 million yuan in H1 2024, a year-on-year increase of 135.51% [7] - The company is investing in the research and development of various sensors, including six-component force sensors, which are expected to enhance precision and open new application areas [7] Market Outlook - The macroeconomic environment in 2024 is expected to recover slowly, but the company anticipates a normalization of special industry orders and additional demand from sensors [2][7] - The projected earnings per share (EPS) for 2024-2026 are 1.04, 1.34, and 1.68 yuan per share respectively [2][7]

Investment Rating - The report maintains a "Buy" rating for the company [3][4]. Core Views - The company's H1 2024 performance met expectations, with steady growth in structural mechanics testing systems and PHM business, and rapid growth in electrochemical workstations, indicating a potential for continued growth [2][3]. - The EPS estimates for 2024-2026 have been raised to 1.23, 1.62, and 2.05 CNY respectively, reflecting an upward adjustment due to the strong performance and market conditions [3]. - The target price has been adjusted down to 35.67 CNY, based on a 29x PE ratio for 2024, which is aligned with industry standards [3][4]. Financial Performance Summary - In H1 2024, the company achieved revenue of 276 million CNY, a year-on-year increase of 37.75%, and a net profit attributable to shareholders of 74 million CNY, up 65.11% year-on-year [3]. - Q2 2024 revenue was 172 million CNY, reflecting a 33.60% year-on-year growth, with a net profit of 47 million CNY, up 35.30% year-on-year [3]. - The structural mechanics performance testing analysis system generated revenue of 190 million CNY in H1 2024, a 41.13% increase year-on-year, while the electrochemical workstation revenue surged by 135.51% to 26 million CNY [3]. Product and Market Insights - The structural mechanics testing system is a domestic leader, benefiting from rapid localization and government support for scientific instrument development [3]. - The PHM system for structural safety and equipment fault prediction generated 40 million CNY in revenue, a 15.78% increase year-on-year, indicating a strong trend towards domestic substitution [3]. - The humanoid robot force sensor business is expected to drive new growth, leveraging the company's leading technology in mechanical performance testing sensors [3].

Investment Rating - The report maintains a "Buy" rating for the company, with a target price of 29.55 CNY [2][4] Core Views - The company achieved significant growth in H1 2024, with revenue reaching 276 million CNY, a 37.75% YoY increase, and net profit attributable to shareholders of 74 million CNY, up 65.11% YoY [1] - The structural mechanics testing and analysis system remains the core business, contributing 190 million CNY in revenue, a 36.24% YoY increase, with a high gross margin of 66.32% [1] - The PHM (Prognostics and Health Management) system and electrochemical workstation businesses are emerging as new growth drivers, with the latter experiencing a 135.51% YoY revenue increase [1] - The company is well-positioned to benefit from domestic substitution policies and increasing demand in both military and civilian sectors [1] Financial Performance - Revenue for 2024E is projected at 1,241 million CNY, with net profit attributable to shareholders of 351 million CNY [3] - EPS for 2024E is forecasted at 1.46 CNY, with a P/E ratio of 20x [2][3] - ROE (Return on Equity) is expected to reach 23.79% in 2024E, up from 13.21% in 2023 [3] - Gross margin is projected to remain stable at around 66% from 2024E to 2026E [6] Business Segments - Structural mechanics testing and analysis system: Core business with strong growth potential, benefiting from military and academic clients [1] - PHM system: Expanding into civilian applications such as water engineering, port machinery, and wind power, with a gross margin of 65.45% [1] - Electrochemical workstation: Rapid growth in academic markets, with revenue reaching 26 million CNY in H1 2024, up 135.51% YoY [1] - Customized measurement and control analysis system: Emerging business with potential to compete with international players like MTS and Moog [1] Valuation and Projections - The company's market capitalization stands at 4.087 billion CNY, with a 3-month turnover rate of 86.09% [4] - Revenue growth is expected to maintain a CAGR of around 30% from 2024E to 2026E [3] - The P/B ratio is projected to decline from 4.8x in 2024E to 3.0x in 2026E, indicating improving valuation metrics [3][6] - EV/EBITDA is forecasted to decrease from 17.2x in 2024E to 9.3x in 2026E, reflecting strong earnings growth [6]